JAK3 - Janus kinase 3 Gene

Species: Canis lupus familiaris (sub-species: familiaris)

Gene Type: protein coding
Gene ID: 610004

About JAK3

Primary_assembly 20: 45,535,982-45,557,946 forward strand.ROS_Cfam_1.0:CM025119.1

This gene has 3 transcripts (splice variants), 103 orthologues and 32 paralogues.

JAK3 Products (3)

mRNA Protein Name
XM_038428207.1 XP_038284135.1 tyrosine-protein kinase JAK3 isoform X1
XM_038428208.1 XP_038284136.1 tyrosine-protein kinase JAK3 isoform X2
XM_038428209.1 XP_038284137.1 tyrosine-protein kinase JAK3 isoform X3

JAK3 Protein Structure

FERM_F1

FERM_F1: cl39717 (40 - 111)

FERM_F2

FERM_F2: cl39028 (125 - 244)

PH-like

PH-like: cl17171 (249 - 361)

SH2

SH2: cl15255 (361 - 457)

PKc_like

PKc_like: cl21453 (520 - 777)

PKc_like

PKc_like: cl21453 (816 - 1098)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 1000
  • 1103 a.a.
Protein Preferred Names Protein Names

tyrosine-protein kinase JAK3

  • Janus kinase 3 (a protein tyrosine kinase, leukocyte)

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (23)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-50856 Ruxolitinib Inhibitor 99.99% Yes
HY-40354 Tofacitinib Inhibitor 99.99% Yes
HY-19569 Upadacitinib Inhibitor 99.98% Yes
HY-15315 Baricitinib Inhibitor 99.97% Yes
HY-50858 Ruxolitinib phosphate Inhibitor 99.97% Yes
HY-40354A Tofacitinib citrate Inhibitor 99.94% Yes
HY-100754 Ritlecitinib Inhibitor 99.80% Yes
HY-16379 Pacritinib Inhibitor 99.93% Yes
HY-18300 Filgotinib Inhibitor 99.77% Yes
HY-19568 Peficitinib Inhibitor 99.43% Yes
HY-15315A Baricitinib phosphate Inhibitor 99.97% Yes
HY-109053 Delgocitinib Inhibitor 99.61% Unkown
HY-13577 Oclacitinib Inhibitor 99.03% Unkown
HY-13577A Oclacitinib monomaleate Inhibitor 99.87% Unkown
HY-18300A Filgotinib maleate Inhibitor 99.88% Yes
HY-100754C Ritlecitinib tosylate Inhibitor 99.65% Yes
HY-112961 Patiromer Inhibitor 95.0% Unkown
HY-50859 Ruxolitinib sulfate Inhibitor / Unkown
HY-19569A Upadacitinib tartrate tetrahydrate Inhibitor / Unkown
HY-19568A Peficitinib hydrobromide Inhibitor / Unkown
HY-100754A Ritlecitinib malonate Inhibitor / Unkown
HY-16379A Pacritinib hydrochloride Inhibitor / Unkown
HY-19568B Peficitinib hydrochloride Inhibitor / Unkown

Clinical Phase

Bioactive Molecules (21)
Cat. No. Product Name Effect
Purity Phase
HY-10961 Momelotinib Inhibitor 98.93% Phase 3
HY-112708 Brepocitinib Inhibitor 99.97% Phase 3
HY-50514 AT9283 Inhibitor 99.67% Phase 3
HY-15999 Cerdulatinib Inhibitor 99.06% Phase 3
HY-12469 Decernotinib Inhibitor 99.91% Phase 3
HY-10962 Momelotinib sulfate Inhibitor 98.63% Phase 3
HY-112724 Ivarmacitinib Inhibitor 99.62% Phase 3
HY-13775 XL019 Inhibitor 99.65% Phase 3
HY-15999A Cerdulatinib hydrochloride Inhibitor 98.96% Phase 3
HY-10963 Momelotinib mesylate Inhibitor / Phase 3
HY-13034 Gandotinib Inhibitor 99.86% Phase 2
HY-130247 Flonoltinib Inhibitor 99.48% Phase 2
HY-15270 BMS-911543 Inhibitor 98.23% Phase 2
HY-19631A Ilginatinib Inhibitor 99.81% Phase 2
HY-156961 Cadefrecitinib Inhibitor 99.81% Phase 2
HY-112708A Brepocitinib P-Tosylate Inhibitor 99.99% Phase 2
HY-19631B Ilginatinib hydrochloride Inhibitor 98.92% Phase 2
HY-19631 Ilginatinib maleate Inhibitor 99.33% Phase 2
HY-130247A Flonoltinib TFA Inhibitor 98.94% Phase 2
HY-10058 AT9283 lactic acid Inhibitor / Phase 2
HY-101024 PF-06263276 Inhibitor ≥99.0% Phase 1

Pre-clinical Phase

Bioactive Molecules (97)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-14435 Pyridone 6 Inhibitor 98.20% Unkown
HY-131140 BD750 Inhibitor 99.02% Unkown
HY-15508 JANEX-1 Inhibitor 99.63% Unkown
HY-145696 SJ10542 Inhibitor 99.32% Unkown
HY-15343 CEP-33779 Inhibitor 99.23% Unkown
HY-145551 Atinvicitinib Inhibitor 98.62% Unkown
HY-10411 AZ960 Inhibitor 97.08% Unkown
HY-14722 NVP-BSK805 Inhibitor 99.30% Unkown
HY-10410 TG101209 Inhibitor 98.81% Unkown
HY-102046 FM-381 Inhibitor 98.08% Unkown
HY-100895 SAR-20347 Inhibitor 97.27% Unkown
HY-108264 TCS 21311 Inhibitor 99.49% Unkown
HY-151262 JAK-IN-23 Inhibitor 98.88% Unkown
HY-12589 ZM39923 hydrochloride Inhibitor 99.84% Unkown
HY-18313 S6K1-IN-1 Inhibitor 99.71% Unkown
HY-11067 WHI-P97 Inhibitor 99.16% Unkown
HY-153701S Envudeucitinibum Inhibitor 99.56% Unkown
HY-101976 JAK3-IN-6 Inhibitor 99.48% Unkown
HY-174280 Modzatinib Inhibitor / Unkown
HY-14722A NVP-BSK805 dihydrochloride Inhibitor 99.36% Unkown
HY-13895 WHI-P154 Inhibitor 98.77% Unkown
HY-19544 JAK3-IN-1 Inhibitor 99.31% Unkown
HY-131906 JAK2-IN-7 Inhibitor 98.31% Unkown
HY-150720 TYK2-IN-12 Inhibitor 98.81% Unkown
HY-150023 BI-1622 Inhibitor 98.02% Unkown
HY-153440 Methyl 6-(1-(4-methoxybenzyl)-1H-pyrazol-4-yl)-4-oxo-4,5-dihydropyrazolo[1,5-a]pyrazine-2-carboxylate Inhibitor 98.01% Unkown
HY-120469 2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide Inhibitor 99.80% Unkown
HY-139423 JAK1-IN-8 Inhibitor 95.0% Unkown
HY-143444 JAK-IN-20 Inhibitor 99.63% Unkown
HY-136336 Tofacitinib metabolite-1 Inhibitor 99.59% Unkown
HY-111750 JAK-IN-3 Inhibitor 98.92% Unkown
HY-126141 JAK/HDAC-IN-1 Inhibitor 98.63% Unkown
HY-13961 GLPG0634 analog Inhibitor 98.07% Unkown
HY-100754B (2R,5S)-Ritlecitinib Inhibitor 99.77% Unkown
HY-152080 Blovacitinib Inhibitor 99.71% Unkown
HY-100849 JAK 3i Inhibitor 99.81% Unkown
HY-13450 ZM 449829 Inhibitor 99.73% Unkown
HY-159536 Frevecitinib Inhibitor 99.42% Unkown
HY-131014 FM-479 99.2% Unkown
HY-170772 Dual Cathepsin L/JAK-IN-1 Inhibitor 98.47% Unkown
HY-161618 MJ04 Inhibitor 98.08% Unkown
HY-119935 JAK3 covalent inhibitor-1 Inhibitor / Unkown
HY-147754 JAK3/BTK-IN-6 Inhibitor / Unkown
HY-155951 JAK3-IN-14 Inhibitor 99.32% Unkown
HY-174430 WWQ-131 Inhibitor / Unkown
HY-N14094 Tubulosine Inhibitor / Unkown
HY-178282 JAK1-IN-19 Inhibitor / Unkown
HY-120457 WYE-151650 Inhibitor / Unkown
HY-151256 JAK-2/3-IN-2 Inhibitor / Unkown
HY-178448 EGFR-IN-178 Inhibitor / Unkown
HY-181663 PJ27 Inhibitor / Unkown
HY-182314 JAK3-IN-20 Inhibitor / Unkown
HY-170723 JAK-IN-39 Inhibitor / Unkown
HY-147975 JAK3-IN-12 Inhibitor / Unkown
HY-168718 FAK-IN-22 Inhibitor / Unkown
HY-124657 PRN-371 Inhibitor / Unkown
HY-151285 JAK-2/3-IN-3 Inhibitor / Unkown
HY-108342 PF-00956980 Inhibitor / Unkown
HY-178755 DEL1187-126-5-80 Inhibitor / Unkown
HY-133747 JAK3-IN-9 Inhibitor / Unkown
HY-176793 JAK1-IN-18 Inhibitor / Unkown
HY-147742 Thi-DPPY Inhibitor / Unkown
HY-151258 TK4g Inhibitor / Unkown
HY-147741 DPPY Inhibitor / Unkown
HY-174999 JAK3-IN-18 Inhibitor / Unkown
HY-149283 JAK/HDAC-IN-2 Inhibitor / Unkown
HY-18949 JI6 Inhibitor / Unkown
HY-115438 AUH-6-96 Inhibitor / Unkown
HY-138222 JANEX-1 hydrochloride Inhibitor / Unkown
HY-149296 JAK1-IN-12 Inhibitor / Unkown
HY-168269 Tyk2-IN-20 Inhibitor / Unkown
HY-178763 DEL1187-126-28-16 Inhibitor / Unkown
HY-168339 Tyk2-IN-22 Inhibitor / Unkown
HY-175684 JAK2-IN-14 Inhibitor / Unkown
HY-10652 JAK-2/3-IN-1 Inhibitor / Unkown
HY-146727 JAK3-IN-11 Inhibitor / Unkown
HY-154994 JAK-IN-30 Inhibitor / Unkown
HY-123099 MS-1020 Inhibitor / Unkown
HY-182361 NUAK1-IN-3 / Unkown
HY-161967 JAK2/FLT3-IN-3 Inhibitor / Unkown
HY-143885 JAK1/TYK2-IN-3 Inhibitor / Unkown
HY-164111 JNK-IN-17 Inhibitor / Unkown
HY-161354 JAK3 covalent inhibitor-2 Inhibitor / Unkown
HY-151259 TK4b Inhibitor / Unkown
HY-173601 JAK3-IN-17 Inhibitor / Unkown
HY-162862 JAK-IN-38 Inducer / Unkown
HY-161912 5TTU Inhibitor / Unkown
HY-123187 AS2553627 Inhibitor / Unkown
HY-130247B Flonoltinib monomaleate Inhibitor / Unkown
HY-180512 JAK3-IN-19 Inhibitor / Unkown
HY-157121 JAK-IN-34 Inhibitor / Unkown
HY-162862 JAK-IN-38 Inhibitor / Unkown
HY-123939 JAK1/3-IN-1 Inhibitor / Unkown
HY-12589A ZM39923 Inhibitor / Unkown
HY-123625 R-348 choline Inhibitor / Unkown
HY-122101 NSC114792 Inhibitor / Unkown
HY-U00390 JAK3-IN-7 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens JAK3 NCBI NCBI:3718